• 

  Next-Generation Alzheimer’s Drugs Show Mixed Results at AAIC
• 

  How Well Do Alzheimer’s Blood Tests Work in the Real World?
• 

  FDA Approves At-Home Injectable Leqembi for Early Alzheimer’s
• 

  THC/CBD Shows Promise for Treating Agitation in Late-Stage Alzheimer’s
• 

  How Artificial Intelligence Could Accelerate Alzheimer’s Diagnosis and Discoveries
• 

  Next-Generation Alzheimer’s Drugs, Blood Tests and Prevention Research Take Center Stage at AAIC
• 

  Inside Look: A Brain Health Lifestyle Trial Participant’s Story
• 

  Ones to Watch: Emerging Tech From AAIC 2025
• 

  AAIC 2025: 7 Big Takeaways from the World’s Largest Alzheimer’s Research Conference
• 

  STUDY: Lead Exposure Decades Ago Could Be Causing Memory Problems Now
• 

  Roche’s ‘Brainshuttle’ Alzheimer’s Drug Heads for Phase 3 Trials
• 

  New Guidelines: When Alzheimer’s Blood Tests Can Replace Scans and Spinal Taps
• 

  POINTER: The Lifestyle Formula That Turned Back the Brain Clock
• 

  AAIC Day 3: Dispatch from the World’s Largest Alzheimer’s Research Conference
• 

  4 Big Questions About New Alzheimer’s Anti-Amyloid Drugs, Answered

12Next